Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Logan

Showing results (321-330 of 372) with videos related to

Pageof 38
Sort By:
Blood|September 20, 2017
Ibrutinib for chronic graft-versus-host disease after failure of prior therapyDavid Miklos, Corey S Cutler, Mukta Arora, et al.
Blood Cancer Journal|November 20, 2024
Frontline Ph-negative B-cell precursor acute lymphoblastic leukemia treatment and the emerging role of blinatumomabElias J Jabbour, Hagop M Kantarjian, Nicola Goekbuget, et al.
Scientific Reports|June 7, 2017
Mass spectrometry imaging identifies palmitoylcarnitine as an immunological mediator during Salmonella Typhimurium infectionHeather E Hulme, Lynsey M Meikle, Hannah Wessel, et al.
Journal of the American Chemical Society|January 4, 2024
Visualizing the Interface of Biotin and Fatty Acid Biosynthesis through SuFEx ProbesAochiu Chen, Rebecca N Re, Tony D Davis, et al.
The Journal of Clinical Investigation|November 15, 2016
Antibody-drug conjugate targeting CD46 eliminates multiple myeloma cellsDaniel W Sherbenou, Blake T Aftab, Yang Su, et al.
Journal for Immunotherapy of Cancer|November 25, 2023
Framework humanization optimizes potency of anti-CD72 nanobody CAR-T cells for B-cell malignanciesWilliam C Temple, Matthew A Nix, Akul Naik, et al.
Science Advances|January 26, 2022
Pore dynamics and asymmetric cargo loading in an encapsulin nanocompartmentJennifer Ross, Zak McIver, Thomas Lambert, et al.
Leukemia & Lymphoma|October 6, 2023
Measurable residual disease conversion rate with consolidation chemotherapy in acute myeloid leukemiaDaria Gaut, Caspian Oliai, Jonathan Boiarsky, et al.
Transplantation and Cellular Therapy|March 27, 2026
Transportability to the European population of Efficacy of Belumosudil as Compared with Physician's Choice of Best Available Therapy for The Treatment of Chronic Graft Versus Host DiseaseDaniel Wolff, Carlos Solano, David Michonneau, et al.
Journal of Cell Science|April 21, 2017
CLUH couples mitochondrial distribution to the energetic and metabolic statusJamal Wakim, David Goudenege, Rodolphe Perrot, et al.
Pageof 38

Showing results (321-330 of 372) with videos related to

Sort By:
Pageof 38
Blood|September 20, 2017
Ibrutinib for chronic graft-versus-host disease after failure of prior therapyDavid Miklos, Corey S Cutler, Mukta Arora, et al.
Blood Cancer Journal|November 20, 2024
Frontline Ph-negative B-cell precursor acute lymphoblastic leukemia treatment and the emerging role of blinatumomabElias J Jabbour, Hagop M Kantarjian, Nicola Goekbuget, et al.
Scientific Reports|June 7, 2017
Mass spectrometry imaging identifies palmitoylcarnitine as an immunological mediator during Salmonella Typhimurium infectionHeather E Hulme, Lynsey M Meikle, Hannah Wessel, et al.
Journal of the American Chemical Society|January 4, 2024
Visualizing the Interface of Biotin and Fatty Acid Biosynthesis through SuFEx ProbesAochiu Chen, Rebecca N Re, Tony D Davis, et al.
The Journal of Clinical Investigation|November 15, 2016
Antibody-drug conjugate targeting CD46 eliminates multiple myeloma cellsDaniel W Sherbenou, Blake T Aftab, Yang Su, et al.
Journal for Immunotherapy of Cancer|November 25, 2023
Framework humanization optimizes potency of anti-CD72 nanobody CAR-T cells for B-cell malignanciesWilliam C Temple, Matthew A Nix, Akul Naik, et al.
Science Advances|January 26, 2022
Pore dynamics and asymmetric cargo loading in an encapsulin nanocompartmentJennifer Ross, Zak McIver, Thomas Lambert, et al.
Leukemia & Lymphoma|October 6, 2023
Measurable residual disease conversion rate with consolidation chemotherapy in acute myeloid leukemiaDaria Gaut, Caspian Oliai, Jonathan Boiarsky, et al.
Transplantation and Cellular Therapy|March 27, 2026
Transportability to the European population of Efficacy of Belumosudil as Compared with Physician's Choice of Best Available Therapy for The Treatment of Chronic Graft Versus Host DiseaseDaniel Wolff, Carlos Solano, David Michonneau, et al.
Journal of Cell Science|April 21, 2017
CLUH couples mitochondrial distribution to the energetic and metabolic statusJamal Wakim, David Goudenege, Rodolphe Perrot, et al.
Pageof 38